Felix Woodhead

[Felix Woodhead @fwoodhead]

@ActionPFsteve @DrMAGibbons @ActionPFcharity @EU_IPFF Fantastic news and well deserved for a true stalwart of UK ILD clinical research

[Steve Jones @ActionPFsteve]

Congratulations to Michael Gibbons on becoming honorary professor at the University of Exeter, in recognition of his research on ILD. A strong advocate for PPI in clinical research. Well deserved! @ActionPFcharity @EU_IPFF #CurePF #CureIPF

[Bristol Academic Respiratory Unit @BristolARU]

*We are recruiting! *
*New consultant post!*

Excellent opportunity to join a friendly & enthusiastic resp team @NorthBristolNHS. Lovely colleagues, modern hospital, dynamic & forward thinking department.

Apply here
https://t.co/TTruJtFXaS

@UKPleura @RespTrainees @respfutures

[National Institute for Health and Care Research @NIHRresearch]

The @recovery_rs trial aims to compare three methods of providing respiratory support to patients with severe symptoms of #COVID19. We urgently need more sites to take part, your Local Clinical Research Network can support with set up and trial delivery https://t.co/x8jvy7thwJ

[Felix Woodhead @fwoodhead]

Very important news from #RECOVERY trial of interventions for #COVID19. Dexamethasone reduces mortality in ventilated pts and those on O2. Great work by UK research team #NIHR

[National Institute for Health and Care Research @NIHRresearch]

The NIHR-supported RECOVERY trial has shown that dexamethasone, a steroid, significantly reduces the risk of dying from #COVID19 for seriously ill patients requiring respiratory intervention - a major breakthrough https://t.co/KITpXiUcMr

#priorityCOVIDresearch

[Leticia Kawano-Dourado (I'm on BlueSky/LinkedIn) @leticiakawano]

So unacceptable! Besides retraction, how are these misconducts punished (legally)?

[Rachael Evans @REvans_Breathe]

Much thanks to @Greening_COPD @fwoodhead Alaistair Moss, Ranjit Arnold @HawkesKayleigh Nicole Toms, Liz Webb, outpatient team, our brilliant secretaries - yet more letters, @NikkiGardiner1, Claire Bourne, @drmanpareek. And hopefully @DrMattGB @confuseddoc for MDT next week 😊

[Leticia Kawano-Dourado (I'm on BlueSky/LinkedIn) @leticiakawano]

1/Hard day.
I´ve seen many eligible patients to Coalition I study (*mild*covid19) but patients kept telling me the same thing: "I wanna recover fast Doc. I don´t want the risk of not getting HCQ & Azythro"

Since when we know that HCQ & Azythro will make covid19 pts heal faster?

[Daniel Hewitt @DanielHewittITV]

I absolutely love this. Could have watched @robosborneitv chat to his mum for hours. Excellent work.

[British Lung Foundation @lunguk]

Thank you for bearing with us whilst we’ve been updating our health advice on #coronavirus. We appreciate it’s a concerning time if you or a loved one lives with a lung condition. We have now updated our info after the government updated their guidance.

https://t.co/mXQ9kEqMAt

[Felix Woodhead @fwoodhead]

Great advice from Steve for all our ILD pts @bedoctored @IPFdoc @JaneScullion @Leic_ILDSupport @LeicResearch @RachaelVDowling @REvans_Breathe

[Action for Pulmonary Fibrosis @ActionPFcharity]

Our Chair of Trustees Steve Jones talks about #selfisolation, and adapting his daily routine to continue doing what he enjoys.

We're here for you. We're in this together 💜

How are you adapting your daily routine?

@ActionPFsteve

[ILFA Ireland @ILFA_Ireland]

All patients with #IPF should immediately self-isolate. This advice was shared with @ILFA_Ireland today from respiratory consultants to ensure your safety as a vulnerable patient with a serious underlying respiratory condition. Follow @HSELive @roinnslainte advice to stay safe.

[Felix Woodhead @fwoodhead]

Nintedanib (antifibrotic shown originally to work in IPF) now approved for non-IPF fibrosing ILD in USA. Not yet approved in UK. For Rheumatoid Arthritis assoc ILD the #TRAIL1 RCT of pirfenidone is running at 11 UK sites with 6 due soon https://t.co/d0Bzkl1PAU @RheumatologyUK

[Boehringer Ingelheim @boehringerus]

#NEWS: #FDA approval of new therapy for use in patients with chronic fibrosing #ILDs in which lung fibrosis continues to worsen marks another milestone in our continued commitment to people with serious lung diseases https://t.co/5SyiWjnW39

[Felix Woodhead @fwoodhead]

Really interesting, particularly the reduction in pneumonia and hospital admissions.

[ILD-IN @ild_inn]

Interesting with regards to our ILD patients

[Leticia Kawano-Dourado (I'm on BlueSky/LinkedIn) @leticiakawano]

Part of the #INKLUDEstudy team trying the best 🍕 in the world 😋: Sao Paulo's pizza! @LouiseVwain @IPFdoc @INKLUDE_gcrf @jade_kettlewell @Juani1000 @israelmaia16

[Action for Pulmonary Fibrosis @ActionPFcharity]

We are delighted with the significance of this research and what it means for patients. Finding 3 new genes linked to IPF should drive treatments for the future. Well done everyone involved in this work @IPFdoc @LouiseVwain @rjallen513

[James D Chalmers @ProfJDChalmers]

I am looking forward to visiting Leicester this week to celebrate 20 years of the Lung Health Institute. Colleagues in Leicester have made a huge contribution to respiratory research into the UK over that time

I'll be talking about the #microbiome in #bronchiectasis and #COPD .

[INJUSTIS Study @INJUSTIS_Study]

Yesterday we recruited our 150th #INJUSTIS patient! Thank you to Sarah at @SFHresearch! Only 100 to go ⚖️@Fasi_Khan10 @lucyjhoward @IPFdoc